Yüklüyor......
Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review
Edoxaban, an oral direct inhibitor of factor Xa, was recently approved in the United States and Japan for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and for treatment of venous thromboembolism (VTE). It is also licensed in Japan for prevention of VTE...
Kaydedildi:
| Yayımlandı: | J Thromb Thrombolysis |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4608015/ https://ncbi.nlm.nih.gov/pubmed/25669624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-015-1185-7 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|